P3 Health Partners Pre-Tax Profit Margin 2020-2025 | PIII

P3 Health Partners pre-tax profit margin from 2020 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
P3 Health Partners Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
2025-03-31 $1.49B $-0.30B -20.27%
2024-12-31 $1.50B $-0.31B -20.40%
2024-09-30 $1.48B $-0.25B -16.87%
2024-06-30 $1.40B $-0.18B -12.84%
2024-03-31 $1.35B $-0.18B -13.24%
2023-12-31 $1.27B $-0.18B -14.45%
2023-09-30 $1.18B $-0.65B -54.89%
2023-06-30 $1.14B $-0.67B -59.28%
2023-03-31 $1.08B $-1.55B -143.92%
2022-12-31 $1.05B $-1.56B -148.62%
2022-09-30 $0.98B $-1.15B -117.52%
2022-06-30 $0.88B $-1.11B -126.02%
2022-03-31 $0.76B $-0.24B -31.58%
2021-12-31 $0.64B $-0.20B -32.03%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.058B $1.500B
P3 Health Partners is a patient-centered and physician-led population health management company. P3 Health Partners, formerly known as Foresight Acquisition Corp., is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $39.174B 54.11
Hims & Hers Health (HIMS) United States $13.701B 142.35
Tempus AI (TEM) United States $10.751B 0.00
IRhythm Technologies (IRTC) United States $4.508B 0.00
Inspire Medical Systems (INSP) United States $4.426B 69.15
Privia Health (PRVA) United States $2.989B 204.33
Enovis (ENOV) United States $1.969B 10.98
Clover Health Investments (CLOV) United States $1.878B 0.00
Schrodinger (SDGR) United States $1.573B 0.00
Phreesia (PHR) United States $1.516B 0.00
Omnicell (OMCL) United States $1.348B 23.78
Azenta (AZTA) United States $1.294B 60.15
10x Genomics (TXG) United States $1.118B 0.00
Fulgent Genetics (FLGT) United States $0.646B 0.00
Butterfly Network (BFLY) United States $0.566B 0.00
Talkspace (TALK) United States $0.502B 150.00
Veradigm (MDRX) United States $0.476B 0.00
Claritev (CTEV) United States $0.472B 0.00
Standard BioTools (LAB) United States $0.399B 0.00
TruBridge (TBRG) United States $0.374B 830.67
Health Catalyst (HCAT) United States $0.274B 0.00
Nyxoah SA (NYXH) Belgium $0.262B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.192B 0.00
EUDA Health Holdings (EUDA) Singapore $0.144B 0.00
Pulmonx (LUNG) United States $0.135B 0.00
American Well (AMWL) United States $0.118B 0.00
MDxHealth SA (MDXH) Belgium $0.102B 0.00
CareCloud (CCLD) United States $0.090B 3.42
Outset Medical (OM) United States $0.070B 0.00
111 (YI) China $0.069B 0.00
Retrieve Medical Holdings (RMHI) United States $0.059B 0.00
HeartBeam (BEAT) United States $0.056B 0.00
Zepp Health (ZEPP) Netherlands $0.039B 0.00
Zhongchao (ZCMD) China $0.031B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
Precipio (PRPO) United States $0.014B 0.00
MSP Recovery (MSPR) United States $0.013B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Streamline Health Solutions (STRM) United States $0.010B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.005B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00